These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3290716)

  • 41. Plasmapheresis in progressive MS.
    Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
    Neurology; 1985 Apr; 35(4):614. PubMed ID: 3982658
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasminogen deficiency and thrombosis after plasmapheresis therapy for multiple sclerosis.
    Smith CD; Latortue R; McFarland JG; Menitove JE
    Neurology; 1986 Oct; 36(10):1410-1. PubMed ID: 3762956
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasma exchange in acute multiple sclerosis. Design of a cooperative study.
    Weiner HL; Dau P; Birnbaum G; Feldstein M; Khatri B; Petajan J; McQuillen MP
    Arch Neurol; 1983 Oct; 40(11):691-2. PubMed ID: 6354152
    [No Abstract]   [Full Text] [Related]  

  • 44. [Plasmapheresis in the treatment of nervous system diseases].
    Zaleska B
    Neurol Neurochir Pol; 1984; 18(5):409-13. PubMed ID: 6527723
    [No Abstract]   [Full Text] [Related]  

  • 45. [Plasmapheresis in neurology. Critical analysis of indications and protocols].
    Seggia JC; Abreu P
    Arq Neuropsiquiatr; 1992 Sep; 50(3):324-8. PubMed ID: 1308410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Childhood multiple sclerosis treated with plasmapheresis.
    Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
    Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence of treatment benefit: is seeing believing or obfuscation by statistics?
    Cutter G
    Mult Scler; 2009 Nov; 15(11):1251-2. PubMed ID: 19965557
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmapheresis in multiple sclerosis: preliminary study.
    Weiner HL; Dawson DM
    Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Multiple sclerosis: an update].
    Duquette P
    Union Med Can; 1988 Aug; 118(3):231-5. PubMed ID: 3051618
    [No Abstract]   [Full Text] [Related]  

  • 51. Complications in patients treated with plasmapheresis in the intensive care unit.
    Szczeklik W; Wawrzycka K; Włudarczyk A; Sega A; Nowak I; Seczyńska B; Fajfer I; Zając K; Królikowski W; Kózka M
    Anaesthesiol Intensive Ther; 2013; 45(1):7-13. PubMed ID: 23572301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppressive drug therapy with plasmapheresis in chronic progressive multiple sclerosis: a controlled study.
    Khatri BO; Harrington GJ; Schmoll D; McQuillen MP
    J Clin Apher; 1984; 2(1):135-7. PubMed ID: 6536654
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasmapheresis in acute multiple sclerosis: rationale and results.
    Dau PC
    J Clin Apher; 1991; 6(4):200-4. PubMed ID: 1816240
    [No Abstract]   [Full Text] [Related]  

  • 54. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
    Wirguin I; Shinar E; Abramsky O
    J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination.
    Rodriguez M; Karnes WE; Bartleson JD; Pineda AA
    Neurology; 1993 Jun; 43(6):1100-4. PubMed ID: 8170550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental therapies for multiple sclerosis: current status.
    Goodkin DE; Ransohoff RM; Rudick RA
    Cleve Clin J Med; 1992; 59(1):63-74. PubMed ID: 1372538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma exchange in multiple sclerosis.
    Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
    Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
    [No Abstract]   [Full Text] [Related]  

  • 58. [Plasmapheresis in acute phase of multiple sclerosis].
    Matsuo H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():191-5. PubMed ID: 26480699
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS).
    Höcker P; Stellamor V; Summer K; Mann M
    Int J Artif Organs; 1984 Jan; 7(1):39-42. PubMed ID: 6698632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vestibular and ocular motor function prior to and after therapeutic apheresis with small plasmafilter in multiple sclerosis.
    Kolev OI; Kenarov P
    J Clin Apher; 2016 Oct; 31(5):470-2. PubMed ID: 26332668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.